Tuberculosis (TB) is an AIDS-defining illness. It is still a significant cause of illness and death in people with HIV around the world.

Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

  • Tuberculosis

    Tuberculosis (TB) is an infection that usually affects the lungs.It can be very serious, particularly for people living with HIV who have a low CD4 count.TB can...

    From: Factsheets

    Information level Level 2
  • TB and HIV

    If HIV has weakened your immune system, you are more vulnerable to tuberculosis (TB). TB is an infection caused by bacteria. It is a serious...

    From: The basics

    Information level Level 1
  • How TB is passed on

    The bacteria that cause tuberculosis (TB) can sometimes pass from one person to another through the air. TB bacteria can sometimes be spread through the...

    From: The basics

    Information level Level 1
  • Treatment for TB and HIV

    If tuberculosis (TB) is making you ill and you also have HIV, then you usually need to take treatment for both TB and HIV.You can...

    From: The basics

    Information level Level 1
  • Diagnosed with HIV at a low CD4 count

    NAM's factsheet on being diagnosed with HIV when already at a low CD4 cell count...

    From: Factsheets

    Information level Level 2

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • Tuberculosis in SA: Three graphs that tell the story

    According to World Health Organization (WHO) estimates, South Africa continues to have one of the highest burdens of tuberculosis (TB) in the world. The burden of a disease refers to the number of infections and deaths within a population and the associated costs of treatment of a specific disease. Here we attempt to tell the story of the burden of TB on human life using several graphs. As the story of TB cannot be separated from that of HIV, we use estimates from both the WHO TB data portal and the Thembisa mathematical model of HIV in South Africa to examine trends in the data from 2000 to 2017.

    08 July 2019 | Spotlight
  • Standard TB tests may not detect infection in certain exposed individuals

    An international collaboration of infectious disease experts has identified a large group of people who appear to have naturally mounted an immune response to TB, a bacterial infection that is the leading cause of infectious disease death worldwide. Nearly 200 people from 2500 households with active TB were clearly exposed to TB for more than 10 years but the two most reliable tests (TST and IGRA) came back negative on repeated tests.

    02 July 2019 | EurekAlert
  • NIH launches large TB prevention trial for people exposed to multidrug-resistant TB

    A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB.

    25 June 2019 | Eurekalert Medicine & Health
  • FDA Advisory Committee Votes Favorably on the Question of the Effectiveness and Safety of Pretomanid in Combination with Bedaquiline and Linezolid for Treatment of Highly Drug-Resistant Forms of Tuberculosis

    Investigational drug pretomanid, developed by non-profit TB Alliance, is under regulatory review for treatment of extensively drug-resistant tuberculosis and treatment-intolerant or non-responsive multidrug-resistant tuberculosis as part of a new investigational regimen that includes bedaquiline and linezolid.

    07 June 2019 | TB Alliance
  • Xpert testing to find TB in people with advanced HIV at diagnosis saves lives, study finds

    A study reported in Clinical Infectious Diseases this week confirms that patients newly diagnosed with HIV who were screened for TB with Xpert technology had higher survival rates in the year that followed than those screened with a point-of-care test using flourescent light-emitting microscopy.

    08 April 2019 | Science Speaks
  • UNAIDS reports mixed progress towards reaching the 2020 target of reducing TB deaths among people living with HIV by 75%

    Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action.

    25 March 2019 | UNAIDS press release
  • Drug resistant strains could become the dominant form of TB in Europe: it’s time to end TB

    If the current situation continues, the majority of tuberculosis (TB) patients in the next generation could be suffering from drug resistant forms of the disease. The latest WHO/European Centre for Disease Prevention and Control (ECDC) report, “Tuberculosis surveillance and monitoring in Europe 2019 (2017 data)”, shows that the European Region is struggling to make sufficient progress to finally end TB. Challenges in timely detection, which result in ongoing transmission, and inadequate treatment are driving resistance. Despite an overall decline in cases, TB remains a major public health issue that is causing patients suffering and perpetuating poverty.

    25 March 2019 | World Health Organization Europe
  • Learning from experience: Five tangible steps to addressing tuberculosis and HIV in 2019

    If we are determined to stop TB among people living with HIV, there are specific steps we can take to do more this year to ensure that people receive the quality of care they are entitled to

    22 March 2019 | International AIDS Society
  • The Lancet: Experts set out targets to eliminate tuberculosis within a generation

    A world free of tuberculosis (TB) is possible by 2045 if increased political will and financial resources are directed towards priority areas including providing evidence-based interventions to everyone, especially to high risk groups, and increasing research to develop new ways to diagnose, treat, and prevent TB. Funding this response will require substantial investments, and accountability mechanisms will be necessary to ensure that promises are kept and targets are reached.

    21 March 2019 | Eurekalert Inf Dis
  • TB CAB statement on safety of using bedaquiline and delamanid together

    he Global TB Community Advisory Board (TB CAB) welcomes the important finding from the AIDS Clinical Trials Group Deliberate Trial that newer drugs bedaquiline and delamanid are safe to use together. These findings should erase any remaining reluctance to use these two important drugs together, as the benefits of these safer drugs outweigh the risks--especially for patients with drug-resistant TB who have few other treatment options.

    14 March 2019 | TB Online
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.